uniQure N.V. (QURE) Key Metrics

NASDAQ: QUREValuation, returns, debt and efficiency ratios over 10 years.

QURE valuation today

Trailing 12 months · as of October 18, 2026
Market cap
$1.51B
Enterprise value
$2.22B
P/E (TTM)
—
Forward P/E
27.9
PEG ratio
—
Price / sales
80.9
10-yr median 36.0
Price / book
9.2
10-yr median 5.7
EV / EBITDA
1.4
Dividend yield
—
Beta
1.06

QURE key metrics, 2016–2025

Fiscal year ended December 31, 2025 · U.S. dollars

QURE valuation Price multiples at each fiscal year-end price.

Price / sales+169.8%
85.5
2025 · hover or tap a bar for each year
2016: 5.6 (−84.2%)2017: 40.3 (+622.0%)2018: 91.0 (+125.7%)2019: 393.7 (+332.5%)2020: 42.8 (−89.1%)2021: 1.9 (−95.7%)2022: 9.9 (+436.7%)2023: 20.4 (+104.7%)2024: 31.7 (+55.5%)2025: 85.5 (+169.8%)
20162025
Price / book
6.9
2025 · hover or tap a bar for each year
2016: 2.2 (−21.1%)2017: 5.9 (+166.7%)2018: 5.7 (−2.7%)2019: 8.9 (+55.1%)2020: 6.6 (−25.8%)2021: 1.6 (−75.2%)2022: 2.2 (+36.5%)2023: 1.6 (−30.2%)2025: 6.9
20162025
Free cash flow yield+8.7 pts
−12.9%
2025 · hover or tap a bar for each year
2016: −63.7% (−66.3 pts)2017: −13.2% (+50.5 pts)2018: −7.8% (+5.4 pts)2019: −3.7% (+4.1 pts)2020: −9.0% (−5.3 pts)2021: 27.8% (+36.8 pts)2022: −15.4% (−43.2 pts)2023: −47.4% (−32.1 pts)2024: −21.7% (+25.8 pts)2025: −12.9% (+8.7 pts)
20162025

QURE valuation history

Fiscal year-endToday10-year median

QURE returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

QURE debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

QURE price vs earnings per share

Share price at year-endEPS (right axis)

QURE key metrics

2016–2025
uniQure N.V. key metrics by fiscal year
2025202420232022202120202019201820172016
Valuation
Market capitalization$1.38B$859.1M$322.7M$1.06B$971.5M$1.61B$2.87B$1.03B$528.6M$140.2M
Enterprise value$1.29B$557.7M−$156.8M$849.5M$550.9M$1.43B$2.56B$835.7M$390.8M$27.9M
P/E ratio————2.9—————
Price / sales85.531.720.49.91.942.8393.791.040.35.6
Price / book6.9—1.62.21.66.68.95.75.92.2
Price / free cash flow————3.6—————
Price / operating cash flow————3.4—————
EV / sales80.120.6-9.98.01.138.2351.874.129.81.1
EV / EBITDA————1.7—————
EV / free cash flow————2.0—————
Earnings yield−14.5%−27.9%−95.6%−12.0%33.9%−7.8%−4.3%−8.1%−15.2%−52.3%
Free cash flow yield−12.9%−21.7%−47.4%−15.4%27.8%−9.0%−3.7%−7.8%−13.2%−63.7%
Dividend yield————————0.0%0.0%
Shareholder yield (dividends + buybacks)————0.0%0.0%0.0%0.0%0.0%0.0%
Share price at fiscal year-end$23.93$17.66$6.77$22.67$20.74$36.13$71.66$28.82$19.59$5.60
Per share
Revenue per share$0.28$0.56$0.33$2.28$11.19$0.84$0.18$0.32$0.49$1.00
Earnings per share−$3.46−$4.92−$6.47−$2.71$7.04−$2.81−$3.11−$2.34−$2.98−$2.93
Operating cash flow per share−$3.09−$3.76−$3.06−$3.10$6.15−$3.03−$2.47−$2.13−$2.38−$2.88
Free cash flow per share−$3.09−$3.83−$3.21−$3.48$5.78−$3.25−$2.63−$2.25−$2.59−$3.57
Cash per share$10.83$7.55$12.96$7.55$11.88$5.51$9.44$6.59$5.91$5.29
Book value per share$3.46−$0.14$4.36$10.19$12.72$5.49$8.08$5.04$3.33$2.54
Tangible book value per share$1.75−$2.06$2.53$8.38$10.79$5.40$7.93$4.88$2.99$2.19
Dividends per share————————$0.00$0.00
Capex per share$0.01$0.07$0.15$0.38$0.37$0.21$0.17$0.12$0.21$0.69
Debt per share$9.33$1.36$2.90$3.06$2.90$1.61$1.83$1.22$0.80$0.81
Shares outstanding57.5M48.6M47.7M46.7M46.8M44.5M40.0M35.6M27.0M25.0M
Change in shares outstanding+18.2%+2.1%+2.0%−0.2%+5.3%+11.2%+12.2%+32.1%+7.8%+13.5%
Returns & profitability
Return on equity (ROE)−207.1%—−90.2%−23.7%78.5%−44.1%−49.4%−61.8%−104.7%−75.5%
Return on invested capital (ROIC)———−51.3%250.3%−223.1%————
Return on assets (ROA)−28.8%−34.5%−40.1%−16.7%57.3%−31.7%−34.4%−34.5%−40.3%−32.3%
Return on tangible assets−27.4%−51.7%−41.4%−20.4%45.8%−37.2%−28.1%−31.1%−40.3%−40.4%
Free cash flow margin—−686.2%−966.3%−152.8%51.6%−384.7%—−711.5%−532.9%−356.0%
Income quality (OCF / net income)————0.87—————
Financial health
Total debt$536.6M$66.1M$138.4M$142.9M$135.7M$71.5M$73.1M$43.5M$21.6M$20.2M
Cash & short-term investments$622.5M$367.5M$617.9M$352.8M$556.3M$244.9M$377.8M$234.9M$159.4M$132.5M
Net debt−$85.9M−$301.5M−$479.5M−$210.0M−$420.5M−$173.4M−$304.7M−$191.4M−$137.8M−$112.3M
Debt / equity2.70—0.670.300.230.290.230.240.240.32
Debt / assets0.650.120.170.200.170.210.160.160.100.11
Net debt / EBITDA————−1.32—————
Current ratio10.439.748.856.2817.099.4712.1511.858.446.34
Quick ratio10.439.748.686.1916.809.3112.0011.798.386.29
Interest coverage-3.0-2.9-6.8-12.241.6-32.8-31.8-40.8-29.1-33.1
Working capital$593.1M$350.2M$578.2M$400.9M$591.5M$231.6M$352.6M$216.6M$143.5M$121.2M
Invested capital$113.0M−$308.2M−$271.8M$266.1M$175.2M$70.5M$18.3M−$11.8M−$47.8M−$48.6M
Tangible asset value$100.8M−$100.2M$120.8M$391.6M$505.5M$240.0M$317.1M$173.9M$80.6M$54.8M
Net current asset value$30.0M−$173.0M$27.8M$247.8M$414.8M$162.4M$258.6M$142.3M$43.9M$17.3M
Graham number————$44.87—————
Graham net-net per share$0.02−$3.93$0.06$4.37$8.37$3.50$6.38$3.97$1.56$0.53
Capital allocation
Dividends paid————————$0$0
Share buybacks (net)————$0$0$0$0$0$0
Dividends + buybacks / free cash flow————0.0%—————
Capex / revenue2.7%12.4%45.2%16.6%3.3%25.3%91.3%37.6%42.6%68.4%
Capex / operating cash flow————6.1%—————
Capex / depreciation0.030.270.602.072.390.891.000.620.742.82
Stock-based compensation / revenue109.8%82.1%221.5%32.1%4.9%58.2%240.8%94.9%77.3%24.8%
R&D / revenue873.9%530.2%1,356.2%185.6%27.4%326.3%1,301.2%663.0%552.2%288.9%
SG&A / revenue405.9%194.2%461.3%51.4%10.9%113.5%460.7%224.3%188.0%97.8%
Efficiency
Days sales outstanding133.167.81,227.6276.222.836.829.629.4149.996.8
Days of inventory on hand——253.7953.4108.713.511.25.65.83.7
Days payables outstanding1,341.9137.5235.3736.245.814.118.216.722.824.1
Cash conversion cycle (days)-1,208.850.01,246.1493.385.636.222.618.3132.976.4
Receivables turnover2.745.380.301.3216.039.9212.3412.412.433.77
Payables turnover0.272.651.550.507.9625.9020.0021.8115.9915.17
Inventory turnover——1.440.383.3627.0332.4864.8063.1598.79
Asset turnover0.020.040.020.140.910.100.020.050.070.11
Average receivables$5.9M$5.0M$53.3M$80.6M$32.7M$3.8M$590,000$909,500$5.4M$6.7M
Average payables$6.2M$6.9M$8.8M$6.7M$3.1M$4.7M$4.7M$3.4M$4.2M$4.8M
Average inventory—$6.0M$9.5M$8.7M$7.4M$4.5M$2.9M$1.1M$1.1M$735,793
Intangibles / total assets11.9%16.8%10.4%12.0%11.2%1.1%1.3%2.1%4.5%4.6%

Computed from QURE's annual financial statements (latest annual report filed March 2, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

QURE valuation and financial ratios

uniQure earned a return on equity of −207.1% in fiscal 2025. It ended the year with $536.6 million of debt and $622.5 million in cash and short-term investments, a net cash position of $85.9 million. The share count rose 129.7% from 25.0M to 57.5M over 9 years.

See the QURE income statement, the QURE chart for price history, or the QURE stock overview for the latest quote and news.

QURE key metrics FAQ

What is uniQure's return on equity?

uniQure's return on equity (ROE) was −207.1% in fiscal 2025: net income of -$199.0 million on average shareholders' equity of $96.1 million.

How much debt does uniQure have?

uniQure had total debt of $536.6 million at the end of fiscal 2025, a debt-to-equity ratio of 2.70 and more cash than debt.

What is uniQure's free cash flow yield?

uniQure generated -$178.0 million of free cash flow in fiscal 2025, a free cash flow yield of −12.9% on its market value at year-end ($1.4 billion).

What is uniQure's current ratio?

uniQure's current ratio was 10.43 at the end of fiscal 2025: current assets were 10.43 times current liabilities.

Biotechnology key metrics